Home Institutions Johns Hopkins clinical trials Institution Directory
Clinical trials at Johns Hopkins Sites in Baltimore, MD
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:12 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1429
Current sort
Recently updated
Campus scope
Johns Hopkins, Baltimore, MD
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 373–384 of 1,429 matching trials with a site at Johns Hopkins, Baltimore, MD.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions BRAF V600E Mutation
Interventions Plixorafenib, Retifanlimab Drug
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Other
Eligibility 18 Years and older
Enrollment 24 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 2
States / cities Baltimore, Maryland • New York, New York
Conditions Oligometastatic Prostate Cancer (OMPC)
Interventions AAA617, piflufolastat (18F), gallium (68Ga) gozetotide (25μg) Drug
Lead sponsor Novartis Pharmaceuticals Industry
Eligibility 18 Years to 100 Years · Male only
Enrollment 450 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2031
U.S. locations 39
States / cities Fayetteville, Arkansas • Los Angeles, California • Palo Alto, California + 30 more
Conditions Head and Neck Squamous Cell Carcinoma
Interventions Pembrolizumab, IO102-103 Drug
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Other
Eligibility 18 Years and older
Enrollment 30 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2023 – 2028
U.S. locations 5
States / cities Washington D.C., District of Columbia • Chicago, Illinois • Baltimore, Maryland + 2 more
Conditions Metastatic Large Cell Neuroendocrine Carcinoma, Metastatic Neuroendocrine Carcinoma, Metastatic Neuroendocrine Neoplasm, Metastatic Small Cell Neuroendocrine Carcinoma
Interventions Cabozantinib S-malate, Ipilimumab, Nivolumab Drug · Biological
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 18 Years and older
Enrollment 17 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 45
States / cities Birmingham, Alabama • Tucson, Arizona • Duarte, California + 35 more
Conditions Major Depression Moderate, Major Depression Severe, Major Depression
Interventions LSD, Risperidone Drug
Lead sponsor Johns Hopkins University Other
Eligibility 21 Years to 70 Years
Enrollment 10 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2027
U.S. locations 1
States / cities Baltimore, Maryland
Conditions High-Risk Localized Prostate Cancer
Interventions EBRT + 6 mo ADT + 177Lu-PSMA-617, EBRT + 24 mo ADT Drug · Radiation
Lead sponsor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Other
Eligibility 18 Years and older · Male only
Enrollment 60 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2033
U.S. locations 1
States / cities Baltimore, Maryland
Conditions Huntington Disease
Interventions Votoplam (blinded), Placebo Drug
Lead sponsor Novartis Pharmaceuticals Industry
Eligibility 21 Years to 70 Years
Enrollment 770 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2026 – 2030
U.S. locations 40
States / cities Birmingham, Alabama • Little Rock, Arkansas • La Jolla, California + 36 more
Conditions Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Interventions NNC6019-0001, Placebo (NNC6019-0001) Drug
Lead sponsor Novo Nordisk A/S Industry
Eligibility 18 Years and older
Enrollment 1,280 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2029
U.S. locations 63
States / cities Phoenix, Arizona • La Jolla, California • Los Angeles, California + 49 more
Conditions Diffuse Cutaneous Systemic Sclerosis, Interstitial Lung Disease
Interventions Tulisokibart, Companion diagnostic ( CDx), Placebo Drug · Diagnostic Test
Lead sponsor Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) Industry
Eligibility 18 Years and older
Enrollment 154 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2026
U.S. locations 20
States / cities Phoenix, Arizona • Los Angeles, California • Palo Alto, California + 14 more
Conditions Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3
Interventions Questionnaire Administration, Radiation Therapy, Telaglenastat Hydrochloride, Temozolomide Other · Radiation · Drug
Lead sponsor National Cancer Institute (NCI) NIH
Eligibility 16 Years and older
Enrollment 23 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2019 – 2027
U.S. locations 25
States / cities Phoenix, Arizona • Scottsdale, Arizona • La Jolla, California + 19 more
Conditions Pancreatic Carcinoma
Interventions Non-Interventional Study Other
Lead sponsor Mayo Clinic Other
Eligibility 18 Years and older
Enrollment 30,000 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2029
U.S. locations 11
States / cities Scottsdale, Arizona • San Francisco, California • Atlanta, Georgia + 8 more
Conditions Relapsing Multiple Sclerosis
Interventions Fenebrutinib, Teriflunomide, Placebo Drug
Lead sponsor Hoffmann-La Roche Industry
Eligibility 18 Years to 55 Years
Enrollment 746 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2027
U.S. locations 32
States / cities Birmingham, Alabama • Homewood, Alabama • Phoenix, Arizona + 28 more About this Johns Hopkins institution page
What this page lists ClinicalTrials.gov records that list Johns Hopkins in Baltimore, MD as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , browse by condition , or browse by U.S. city .